Skip to main content

Table 2 Anthropometric, dietary and serum variables in the subject groups after vitamin D3 supplementation and changes in variables between measurement periods

From: A 12-week double-blind randomized clinical trial of vitamin D3supplementation on body fat mass in healthy overweight and obese women

Characteristics

Vitamin D group

Placebo group

P-valuea

 

Week 12

Changeb

Week 12

Change

 

Body weight (kg)

73.5±10.43

-0.3±1.5

75±12.3

-0.1±1.7

0.71

Waist circumference (cm)

89.5±8.8

-0.3±4.3

91.6±13

0.4±4.1

0.38

Hip circumference (cm)

107.6±7.9

-0.39±2.4

107.3±7.2

-0.9±2.4

0.36

BMI (kg/m2)

30±4

-0.13±0.6

29.5±4.6

-0.04±0.6

0.50

Fat mass(kg)

28.2±7.5

-2.7±2.1

28.6±8.9

-0.47±2.1

<0.001

Fat free mass (kg)

45.5±4.9

1.8±2.1

46.2±5

0.4±2.1

<0.001

Physical activity (METminutes/week)

892±1488

-10±1627

1081±1372

379±1137

0.23

Energy intake (kcal/d)

2010±1289

143.7±1358.4

1852±992

-208±920.9

0.32

Carbohydrate intake (g/d)

312±186

31.8±194.6

294±164

-34.3±143

0.23

Fiber intake (g/d)

16±12

1±11.7

14±7

-4.3±11.3

0.10

Protein intake (g/d)

72±53

7.8±54.3

66±32

-9.3±35.6

0.29

Fat intake (g/d)

53±43

-2.3±52.2

45±36

-4.2±39.3

0.48

Dietary calcium intake (mg/d)

829±533

-43.9±674.4

625±454

-51.8±509.5

0.18

Dietary vitamin D intake (μg/d)

0.4±0.47

-0.09±0.77

0.37±0.35

-0.04±0.52

0.70

25(OH) D (nmol/L)

75±22

38.2±32

51.5±31

4.6±14

<0.001

PTH (pmol/L)

1.2±0.5

-0.2±0.5

1.7±0.8

0.2±0.5

<0.001

Calcium (mmol/L)

2.2±0.1

-0.02±0.1

2.3±0.09

-0.02±0.1

0.81

Phosphorus (mmol/L)

0.9±0.09

-0.12±0.1

1±0.09

-0.09±0.1

0.21

  1. aAn analysis of covariance (ANCOVA) was used to adjust mean differences on all dependent variables.
  2. bAfter 12 weeks.
  3. Mean ± SD (all such values).